COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Micronoma develops microbiome-based liquid biopsy diagnostics using its Oncobiota™ platform to analyze microbial nucleic acids from blood and tissues for multi-cancer detection, initially focusing on early-stage lung cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
